Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at $35 per month. The Novo Nordisk settlement reached on Jan. 27 ...
Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...
Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback